期刊文献+

Effects of Xuezhikang(血脂康) and Pravastatin on Circulating Endothelial Progenitor Cells in Patients with Essential Hypertension 被引量:6

Effects of Xuezhikang(血脂康) and Pravastatin on Circulating Endothelial Progenitor Cells in Patients with Essential Hypertension
原文传递
导出
摘要 Objective:To investigate the impacts of Xuezhikang(血脂康,XZK)or pravastatin combined with antihypertensive drugs on circulating endothelial progenitor cells(CEPCs)in essential hypertensive (EH)patients.Methods:Eighty-eight EH patients were enrolled into the study and randomly assigned to the antihypertensive drug treatment group(ATH group,29 cases),the pravastatin treatment group(PRA group,29 cases)and the Xuezhikang treatment group(XZK group,30 cases).Patients in the 3 groups were treated with routine antihy... Objective:To investigate the impacts of Xuezhikang(血脂康,XZK)or pravastatin combined with antihypertensive drugs on circulating endothelial progenitor cells(CEPCs)in essential hypertensive (EH)patients.Methods:Eighty-eight EH patients were enrolled into the study and randomly assigned to the antihypertensive drug treatment group(ATH group,29 cases),the pravastatin treatment group(PRA group,29 cases)and the Xuezhikang treatment group(XZK group,30 cases).Patients in the 3 groups were treated with routine antihy...
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2009年第4期266-271,共6页 中国结合医学杂志(英文版)
关键词 essential hypertension endothelial progenitor cell PRAVASTATIN Xuezhikang essential hypertension endothelial progenitor cell pravastatin Xuezhikang
  • 相关文献

参考文献1

二级参考文献11

  • 1Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes [J]. N Engl J Med, 2005, 353 (10) : 999 - 1007.
  • 2Schmidt LC, Rossig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events : proof of concept for the clinical importance of endogenous vascular repair [J]. Circulation, 2005, 111 (22): 2981-2987.
  • 3中国高血压防治指南修订委员会.中国高血压防治指南[M].2005年修订版.北京:人民卫生出版社,2005.14.
  • 4Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis [ J ]. Science, 1997, 275 (5302) : 964 -967.
  • 5Hirsch AT. Vascular disease, hypertension, and prevention: "from endothelium to clinic events" [ J ]. JACC, 2003, 42 (2) : 377 - 379.
  • 6Hristov M, Erl W, Linder S, et al. Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro [J]. Blood, 2004, 104 (9) : 2761 - 2766.
  • 7Gulati R, Jevremovic D, Peterson TE, et al. Autologous culture - modified mononuclear cells confer vascular protection after arterial injury [J]. Circulation, 2003, 108 (12): 1520-1526.
  • 8Strehlow K, Werner N, Berweiler J, et al. Estrogen increases bone marrow - derived endothelial progenitor cell production and diminishes neointima forruation [ J ]. Circulation, 2003, 107 ( 24 ) : 3059 - 3065.
  • 9Imanishi T, Kobayashi K, Hano T, et al. Effect of estrogen on differentiation and senescence in endothelial progenitor cells derived frombone marrow in spontaneously hypertensive rats [ J]. Hypertens Res, 2005, 28 (9): 763-772.
  • 10Imanishi T, Hano T, Nishio I. Angiotensin Ⅱ accelerates endothelial progenitor cell senescence through induction of oxidative stress [ J]. J Hypertens, 2005, 23 ( 1 ) : 97 - 104.

共引文献3

同被引文献114

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部